Friday, October 30, 2026

Samsung Electronics Taps Galaxy S25 Ultra to Live-Stream the Milan-Cortina 2026 Opening Ceremony From San Siro Stadium

Samsung's Galaxy S25 Ultra will enhance the 2026 Winter Olympics with live streaming, real-time translation, and innovative technology support.

Elon Musk Teases X Money, a New Banking App Born from Twitter

Elon Musk has begun beta testing for X Money, a new banking app set for 2025, with limited access and licenses in 41 states.

From Keycaps to World Cup Matches, K-Bio Turns BIO USA Into a Marketing Showcase

The BIO International Convention 2026 showcased innovative marketing and cultural engagement, enhancing the biotech industry's global appeal.

Health

Unlock Your Health: Discover the New AI-Powered BioAge and Health Coach Services from DaNaA Data

Daewoo Group's AI health data firm, DaNaA Data, launched a service analyzing biological age, disease risk, and health check results.

How the New Medical School in Namwon Can Transform Regional Healthcare: Insights from Lawmaker Park Ji-won

Defining school locations alone won't solve local healthcare issues; deeper strategies are needed for effective solutions.

Ardens Lifescience Triumphs: How a Korean Startup Won 175,000 USD at MedTech Innovator APAC 2026

Adenz Life Sciences wins a global medical device competition, earning a prize of 175,000 USD.

Unlocking the Future of Healthcare: Daewoong’s AI-Powered Smart Hospital at AI EXPO MARS 2026

Daewoong Pharmaceutical introduces an AI-based smart hospital model for monitoring, diagnosis, testing, and rehabilitation.

10 Years of Excellence: Seoul’s APLAR Center Hosts International Rheumatology Training for Young Specialists

Seoul St. Mary's Hospital's Rheumatology Center held an international training program for foreign experts on October 27 and 26.
Latest

Samsung Biologics Cuts Development Time for Next-Gen Biopharmaceuticals by 27%: Discover the New Process

Samsung Biologics enhances its CDO business by reducing the development time for next-gen biopharmaceuticals from 13 to 9 months.

Noul to Supply AI-Powered Cervical Cancer Diagnostic Devices to Bosnia, Expanding European Presence

South Korean medical AI company Noul has signed a three-year supply agreement for its miLab CER cervical cancer diagnostic solution in Bosnia and Herzegovina, marking an expansion into the Balkans as it seeks to grow its European business.

Inventage Lab Files for Phase 1 Australian Trial of Once-Monthly Obesity Drug

Inventage Lab has applied to begin an Australian Phase 1 clinical trial of IVL3021, a long-acting semaglutide injection designed for monthly dosing, to assess its pharmacokinetics and safety and support potential global partnerships and licensing deals.

Daewoong Pharmaceutical’s Enavogliflozin Cuts Leptin Levels Twice as Much as Another Diabetes Drug, Study Finds

A pooled analysis of clinical trial data found that Daewoong Pharmaceutical’s diabetes drug Enblo reduced blood leptin levels approximately twice as much as dapagliflozin over 24 weeks, while also showing greater improvement in an insulin resistance index.

Personalized Treatment to Combat Antibiotic-Resistant Bacteria: Commercialization Target Set for 2030 [Interview]

Researchers at Hallym University and Sweden’s Uppsala University are developing CombiANT, a diagnostic technology designed to identify the most effective antibiotic combinations for individual patients, with commercialization targeted for 2030.

WHO-Recommended Tuberculosis Treatment Shows Comparable Efficacy and Safety in South Korean Patients

A prospective study of South Korean patients with isoniazid-resistant pulmonary tuberculosis found that the six-month WHO-recommended regimen achieved treatment outcomes and safety comparable to those of an alternative regimen.

2026 BIX: How AI is Reshaping Korea’s Biotech Landscape Amid Investment Challenges

The bio industry has felt increasingly neglected over the past year, highlighting significant trends and concerns.

Revolutionary Cancer Treatment: GI-102 Subcutaneous Injection Results to be Unveiled at ESMO IO 2026

GI Innovation will present clinical results of its next-generation immuno-oncology drug GI-102 at an international conference in December.

2026: Discover the Breakthrough NV01-A02 Autism Treatment Revolutionizing Lives

Embracing diversity is essential; autism is a part of this human spectrum, deserving respect and understanding in society.

Inibio’s Botulinum Toxin Inibo Secures NMPA Approval: What This Means for the Chinese Market in 2027

Inibio's botulinum toxin product Inibo has received approval from China's NMPA, with plans for commercialization and global expansion.

L&C Bio Secures U.S. Patent for Innovative Wound Healing Technology: What This Means for the Global Regenerative Medicine Market

L&C Bio secures U.S. patent for wound healing technology using human skin-derived extracellular matrix, enhancing global market competitiveness.

Samsung Gets South Korean Approval for Galaxy Watch Feature That Grades Sleep-Related Breathing Problems

Samsung Electronics has received South Korean regulatory approval for an AI-powered Galaxy wearable feature that classifies sleep-related breathing problems into three levels, with a rollout planned from November for select Galaxy Watch models and the Galaxy Ring.

MediPost to Launch Stem Cell Banking Service Using Locally Developed Culture Media in November

MediPost plans to launch a stem cell banking service in November using animal-origin-free chemically defined culture media developed by ExcelThera, expanding its contract development and manufacturing organization (CDMO) business for cell and gene therapies.

[Healthy at 100] Child’s Eyes Looking Misaligned? Untreated Strabismus Can Lead to Lazy Eye

Childhood strabismus, a condition in which the eyes point in different directions, can impair vision development and lead to amblyopia if left untreated, making early detection and regular eye examinations essential.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.